Clinical Trial Update: Epidiolex in Obsessive Compulsive Disorder and Related Disorders [Phase 2]

View source ↗

Summary

A Phase 2 trial of Epidiolex (cannabidiol) for obsessive-compulsive and related disorders has completed, studying OCD, trichotillomania, Tourette syndrome, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hoarding Disorder
• Obsessive-compulsive Disorder
• Tourette Syndrome
• Trichotillomania

Drugs mentioned

• EPIDIOLEX (Cannabidiol)

Snippet

Sponsor: University of Chicago | Conditions: Obsessive-Compulsive Disorder, Trichotillomania (Hair-Pulling Disorder) | Phase 2 | Status: COMPLETED